| Literature DB >> 24607225 |
Ashley E Frakes1, Laura Ferraiuolo2, Amanda M Haidet-Phillips2, Leah Schmelzer2, Lyndsey Braun2, Carlos J Miranda2, Katherine J Ladner3, Adam K Bevan1, Kevin D Foust4, Jonathan P Godbout4, Phillip G Popovich4, Denis C Guttridge3, Brian K Kaspar5.
Abstract
Neuroinflammation is one of the most striking hallmarks of amyotrophic lateral sclerosis (ALS). Nuclear factor-kappa B (NF-κB), a master regulator of inflammation, is upregulated in spinal cords of ALS patients and SOD1-G93A mice. In this study, we show that selective NF-κB inhibition in ALS astrocytes is not sufficient to rescue motor neuron (MN) death. However, the localization of NF-κB activity and subsequent deletion of NF-κB signaling in microglia rescued MNs from microglial-mediated death in vitro and extended survival in ALS mice by impairing proinflammatory microglial activation. Conversely, constitutive activation of NF-κB selectively in wild-type microglia induced gliosis and MN death in vitro and in vivo. Taken together, these data provide a mechanism by which microglia induce MN death in ALS and suggest a novel therapeutic target that can be modulated to slow the progression of ALS and possibly other neurodegenerative diseases by which microglial activation plays a role.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24607225 PMCID: PMC3978641 DOI: 10.1016/j.neuron.2014.01.013
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173